TrAp: A tree approach for fingerprinting subclonal tumor composition

Nucleic Acids Research

Volumn 41, Issue 17, 2013, Pages

  Strino, Francesco ^a   Parisi, Fabio ^a   Micsinai, Mariann ^a,b   Kluger, Yuval ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CALCULATION; CELL SUBPOPULATION; CLONAL EVOLUTION; COMPUTER MODEL; CONTROLLED STUDY; DNA FINGERPRINTING; EXOME; GENE FREQUENCY; GENETIC ALGORITHM; GENOME ANALYSIS; HUMAN; KARYOTYPE EVOLUTION; KIDNEY CARCINOMA; MATHEMATICAL ANALYSIS; MELANOMA METASTASIS; MUTATIONAL ANALYSIS; PHYLOGENETIC TREE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIMULATION; SINGLE CELL ANALYSIS; SOMATIC HYPERMUTATION; TUMOR BIOPSY;

ALGORITHMS; ALLELES; BIOPSY; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CLONAL EVOLUTION; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; LEUKEMIA, MYELOID, ACUTE; MELANOMA; MUTATION; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84884963475     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt641     Document Type: Article

References (136)

1. Nowell,P. (1976) The clonal evolution of tumor cell populations. Science, 194, 23-28.
2. Greaves,M. and Maley,C.C. (2012) Clonal evolution in cancer. Nature, 481, 306-313.
3. Anderson,K., Lutz,C., van Delft,F.W., Bateman,C.M., Guo,Y., Colman,S.M., Kempski,H., Moorman,A.V., Titley,I., Swansbury,J. et al. (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature, 469, 356-361.
4. Cairns,J. (2006) Mutation selection and the natural history of cancer. Sci. Aging Knowledge Environ., 2006, cp1.
5. Klein,C.A. (2009) Parallel progression of primary tumours and metastases. Nat. Rev. Cancer, 9, 302-312.
6. Gerlinger,M., Rowan,A.J., Horswell,S., Larkin,J., Endesfelder,D., Gronroos,E., Martinez,P., Matthews,N., Stewart,A., Tarpey,P. et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med., 366, 883-892.
7. Campbell,P.J., Pleasance,E.D., Stephens,P.J., Dicks,E., Rance,R., Goodhead,I., Follows,G.A., Green,A.R., Futreal,P.A. and Stratton,M.R. (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl Acad. Sci. USA, 105, 13081-13086.
8. Hanahan,D. and Weinberg,R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
9. Podlaha,O., Riester,M., De,S. and Michor,F. (2012) Evolution of the cancer genome. Trends Genet., 28, 155-163.
10. Shah,S.P., Roth,A., Goya,R., Oloumi,A., Ha,G., Zhao,Y., Turashvili,G., Ding,J., Tse,K., Haffari,G. et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486, 395-399.
11. Notta,F., Mullighan,C.G., Wang,J.C.Y., Poeppl,A., Doulatov,S., Phillips,L.A., Ma,J., Minden,M.D., Downing,J.R. and Dick,J.E. (2011) Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature, 469, 362-367.
12. Driessens,G., Beck,B., Caauwe,A., Simons,B.D. and Blanpain,C. (2012) Defining the mode of tumour growth by clonal analysis. Nature, 488, 527-530.
13. Chen,J., Li,Y., Yu,T.S., McKay,R.M., Burns,D.K., Kernie,S.G. and Parada,L.F. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 488, 522-526.
14. Schepers,A.G., Snippert,H.J., Stange,D.E., vanden Born,M., van Es,J.H., vande Wetering,M. and Clevers,H. (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science, 337, 730-735.
15. Loeb,L.A. (2011) Human cancers express mutator phenotypes: origin, consequences and targeting. Nat. Rev. Cancer, 11, 450-457.
16. Park,S.Y., Gö nen,M., Kim,H.J., Michor,F. and Polyak,K. (2010) Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J. Clin. Invest., 120, 636-644.
17. Walter,M.J., Shen,D., Ding,L., Shao,J., Koboldt,D.C., Chen,K., Larson,D.E., McLellan,M.D., Dooling,D., Abbott,R. et al. (2012) Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med., 366, 1090-1098.
18. Ding,L., Ley,T.J., Larson,D.E., Miller,C.A., Koboldt,D.C., Welch,J.S., Ritchey,J.K., Young,M.A., Lamprecht,T., McLellan,M.D. et al. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature, 481, 506-510.
19. Merlo,L.M., Shah,N.A., Li,X., Blount,P.L., Vaughan,T.L., Reid,B.J. and Maley,C.C. (2010) A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev. Res. (Phila.), 3, 1388-1397.
20. Bedard,P.L. and Sotiriou,C. (2010) Decoding the evolution of a breast cancer genome. EMBO Mol. Med., 2, 3-5.
21. Bellamy,W.T., Dalton,W.S., Gleason,M.C., Grogan,T.M. and Trent,J.M. (1991) Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res., 51, 995-1002.
22. Read,A.F., Day,T. and Huijben,S. (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc. Natl Acad. Sci. USA, 108(Suppl. 2), 10871-10877.
23. Stratton,M. (2011) Evolution of the Cancer Genome. Eur. J. Cancer, 47, S35.
24. Yates,L.R. and Campbell,P.J. (2012) Evolution of the cancer genome. Nat. Rev. Genet., 13, 795-806.
25. Crespi,B. and Summers,K. (2005) Evolutionary biology of cancer. Trends Ecol. Evol., 20, 545-552. (Pubitemid 41323711)
26. Rodriguez-Brenes,I.A., Komarova,N.L. and Wodarz,D. (2011) Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers. Proc. Natl Acad. Sci. USA, 108, 18983-18988.
27. Iacobuzio-Donahue,C.A. (2012) Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Gut, 61, 1085-1094.
28. Anderson,G.R., Stoler,D.L., Kahlenberg,M.S. and Petrelli,N.J. (1998) Genomic instability in sporadic colorectal cancer-A destabilized genome producing accelerated cellular evolution as the fundamental nature of cancer. In: Mihich,E. and Croce,C. (eds), The Biology of Tumors. Springer, New York, pp. 51-56.
29. Marusyk,A., Almendro,V. and Polyak,K. (2012) Intra-tumour heterogeneity: a looking glass for cancer? Br. J. Cancer, 12, 323-334.
30. Hazlehurst,L.A., Foley,N.E., Gleason-Guzman,M.C., Hacker,M.P., Cress,A.E., Greenberger,L.W., De Jong,M.C. and Dalton,W.S. (1999) Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res., 59, 1021-1028. (Pubitemid 29135961)
31. Zhang,Q.C. and Austin,R.H. (2012) Physics of Cancer: The Impact of Heterogeneity. Annu. Rev. Condensed Matter Phys., 3, 363-382.
32. Hampton,O.A., Den Hollander,P., Miller,C.A., Delgado,D.A., Li,J., Coarfa,C., Harris,R.A., Richards,S., Scherer,S.E., Muzny,D.M. et al. (2009) A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res., 19, 167-177.
33. Silva,A.S. and Gatenby,R.A. (2010) A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biol. Direct., 5, 25.
34. Parisi,F., Micsinai,M., Strino,F., Ariyan,S., Narayan,D., Bacchiocchi,A., Cheng,E., Xu,F., Li,P., Kluger,H. et al. (2012) Integrated analysis of tumor samples sheds light on tumor heterogeneity. Yale J. Biol. Med., 85, 347-361.
35. Mullighan,C.G., Phillips,L.A., Su,X., Ma,J., Miller,C.B., Shurtleff,S.A. and Downing,J.R. (2008) Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science, 322, 1377-1380. (Pubitemid 352775249)
36. Fidler,I.J. and Kripke,M.L. (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-895. (Pubitemid 8168759)
37. Bouabdallah,R., Abéna,P., Chetaille,B., Aurran-Schleinitz,T., Sainty,D., Dubus,P., Arnoulet,C., Coso,D., Xerri,L. and Gastaut,J.A. (2001) True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms. Br. J. Haematol., 113, 1047-1050. (Pubitemid 32634775)
38. Feldman,A.L., Berthold,F., Arceci,R.J., Abramowsky,C., Shehata,B.M., Mann,K.P., Lauer,S.J., Pritchard,J., Raffeld,M. and Jaffe,E.S. (2005) Clonal relationship between precursor Tlymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol., 6, 435-437. (Pubitemid 40753750)
39. Feldman,A.L., Arber,D.A., Pittaluga,S., Martinez,A., Burke,J.S., Raffeld,M., Camos,M., Warnke,R. and Jaffe,E.S. (2008) Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood, 111, 5433-5439.
40. Shah,S.P., Morin,R.D., Khattra,J., Prentice,L., Pugh,T., Burleigh,A., Delaney,A., Gelmon,K., Guliany,R., Senz,J. et al. (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature, 461, 809-813.
41. Lambert,G., Estévez-Salmeron,L., Oh,S., Liao,D., Emerson,B.M., Tlsty,T.D. and Austin,R.H. (2011) An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat. Rev. Cancer, 11, 375-382.
42. Barretina,J., Caponigro,G., Stransky,N., Venkatesan,K., Margolin,A.A., Kim,S., Wilson,C.J., Lehar,J., Kryukov,G.V., Sonkin,D. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
43. Dalton,W.S., Durie,B.G., Alberts,D.S., Gerlach,J.H. and Cress,A.E. (1986) Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res., 46, 5125-5130. (Pubitemid 16008277)
44. Durrett,R. and Moseley,S. (2010) Evolution of resistance and progression to disease during clonal expansion of cancer. Theor. Popul. Biol., 77, 42-48.
45. Iwasa,Y., Nowak,M.A. and Michor,F. (2006) Evolution of resistance during clonal expansion. Genetics, 172, 2557-2566.
46. Gerlinger,M. and Swanton,C. (2010) How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br. J. Cancer, 103, 1139-1143.
47. Boyd,S.D., Marshall,E.L., Merker,J.D., Maniar,J.M., Zhang,L.N., Sahaf,B., Jones,C.D., Simen,B.B., Hanczaruk,B., Nguyen,K.D. et al. (2009) Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med., 1, 12ra23.
48. Greulich,P., Waclaw,B. and Allen,R.J. (2012) Mutational pathway determines whether drug gradients accelerate evolution of drugresistant cells. Phys. Rev. Lett., 109, 088101.
49. Aktipis,C.A., Kwan,V.S.Y., Johnson,K.A., Neuberg,S.L. and Maley,C.C. (2011) Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One, 6, e26100.
50. Campbell,P.J., Yachida,S., Mudie,L.J., Stephens,P.J., Pleasance,E.D., Stebbings,L.A., Morsberger,L.A., Latimer,C., McLaren,S., Lin,M.L. et al. (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature, 467, 1109-1113.
51. Saunders,N.A., Simpson,F., Thompson,E.W., Hill,M.M., Endo-Munoz,L., Leggatt,G., Minchin,R.F. and Guminski,A. (2012) Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol. Med., 4, 675-684.
52. Roesch,A., Fukunaga-Kalabis,M., Schmidt,E.C., Zabierowski,S.E., Brafford,P.A., Vultur,A., Basu,D., Gimotty,P., Vogt,T. and Herlyn,M. (2010) A temporarily distinct subpopulation of slowcycling melanoma cells is required for continuous tumor growth. Cell, 141, 583-594.
53. Fidler,I.J. and Kripke,M.L. (2003) Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat. Genet., 34, 23-23.
54. Gatenby,R.A., Silva,A.S., Gillies,R.J. and Frieden,B.R. (2009) Adaptive therapy. Cancer Res., 69, 4894-4903.
55. Huang,S., Hö lzel,M., Knijnenburg,T., Schlicker,A., Roepman,P., McDermott,U., Garnett,M., Grernrum,W., Sun,C., Prahallad,A. et al. (2012) MED12 controls the response to multiple cancer drugs through regulation of TGF-b receptor signaling. Cell, 151, 937-950.
56. Avner,B.S., Fialho,A.M. and Chakrabarty,A.M. (2012) Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework. Bioengineered, 3, 262-270.
57. Lee,M.J., Ye,A.S., Gardino,A.K., Heijink,A.M., Sorger,P.K., MacBeath,G. and Yaffe,M.B. (2012) Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell, 149, 780-794.
58. Xia,Z., Zhang,L., Chen,Q., Royal,C., Yu,Z., Liu,Z. and Adam,B.L. (2009) Stable reversal of multidrug resistance in colon cancer cells by RNA interference targeting the MDR1 gene. Mol. Med. Report, 2, 579-584.
59. Szaká cs,G., Paterson,J.K., Ludwig,J.A., Booth-Genthe,C. and Gottesman,M.M. (2006) Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov., 5, 219-234. (Pubitemid 43336035)
60. Diaz-Cano,S.J. (2012) Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int. J. Mol. Sci., 13, 1951-2011.
61. Lee,A.J.X. and Swanton,C. (2012) Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochem. Pharmacol., 83, 1013-1020.
62. Navin,N., Kendall,J., Troge,J., Andrews,P., Rodgers,L., McIndoo,J., Cook,K., Stepansky,A., Levy,D., Esposito,D. et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature, 472, 90-94.
63. Irish,J.M., Hovland,R., Krutzik,P.O., Perez,O.D., Bruserud,O., Gjertsen,B.T. and Nolan,G.P. (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell, 118, 217-228. (Pubitemid 38962577)
64. Xu,X., Hou,Y., Yin,X.Y., Bao,L., Tang,A.F., Song,L.T., Li,F.Q., Tsang,S., Wu,K., Wu,H.J. et al. (2012) Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a Kidney Tumor. Cell, 148, 886-895.
65. Hou,Y., Song,L.T., Zhu,P., Zhang,B., Tao,Y., Xu,X., Li,F.Q., Wu,K., Liang,J., Shao,D. et al. (2012) single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell, 148, 873-885.
66. Nik-Zainal,S., Van Loo,P., Wedge,D.C., Alexandrov,L.B., Greenman,C.D., Lau,K.W., Raine,K., Jones,D., Marshall,J., Ramakrishna,M. et al. (2012) The life history of 21 breast cancers. Cell, 149, 994-1007.
67. Navin,N. and Hicks,J. (2011) Future medical applications of single-cell sequencing in cancer. Genome Med., 3, 31.
68. Sjö ,L.D., Poulsen,C.B., Hansen,M., Møller,M.B. and Ralfkiaer,E. (2007) Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. Eur. J. Haematol., 79, 501-507. (Pubitemid 350126679)
69. Varma,M. and Jasani,B. (2005) Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology, 47, 1-16. (Pubitemid 40978808)
70. Yamamoto,N., Yang,M., Jiang,P., Xu,M., Tsuchiya,H., Tomita,K., Moossa,A.R. and Hoffman,R.M. (2003) Determination of clonality of metastasis by cell-specific colorcoded fluorescent-protein imaging. Cancer Res., 63, 7785-7790. (Pubitemid 37466710)
71. Attolini,C.S.O. and Michor,F. (2009) Evolutionary theory of cancer. Ann. N. Y. Acad. Sci., 1168, 23-51.
72. Navin,N., Krasnitz,A., Rodgers,L., Cook,K., Meth,J., Kendall,J., Riggs,M., Eberling,Y., Troge,J., Grubor,V. et al. (2010) Inferring tumor progression from genomic heterogeneity. Genome Res., 20, 68-80.
73. Halaban,R., Zhang,W., Bacchiocchi,A., Cheng,E., Parisi,F., Ariyan,S., Krauthammer,M., McCusker,J.P., Kluger,Y. and Sznol,M. (2010) PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells. Pigment Cell Melanoma Res., 23, 190-200.
74. Banerji,S., Cibulskis,K., Rangel-Escareno,C., Brown,K.K., Carter,S.L., Frederick,A.M., Lawrence,M.S., Sivachenko,A.Y., Sougnez,C., Zou,L. et al. (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature, 486, 405-409.
75. Matsushita,H., Vesely,M.D., Koboldt,D.C., Rickert,C.G., Uppaluri,R., Magrini,V.J., Arthur,C.D., White,J.M., Chen,Y.S., Shea,L.K. et al. (2012) Cancer exome analysis reveals a T-celldependent mechanism of cancer immunoediting. Nature, 482, 400-404.
76. Varela,I., Tarpey,P., Raine,K., Huang,D., Ong,C.K., Stephens,P., Davies,H., Jones,D., Lin,M.L., Teague,J. et al. (2011) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature, 469, 539-542.
77. Alexandrov,L.B., Nik-Zainal,S., Wedge,D.C., Campbell,P.J. and Stratton,M.R. (2013) Deciphering signatures of mutational processes operative in human cancer. Cell Rep., 3, 246-259.
78. Lee,D.D. and Seung,H.S. (1999) Learning the parts of objects by non-negative matrix factorization. Nature, 401, 788-791.
79. Hyvä rinen,A. (1999) Fast and robust fixed-point algorithms for independent component analysis. IEEE Trans. Neural. Netw., 10, 626-634.
80. Attias,H. (1999) Independent factor analysis. Neural. Comput., 11, 803-851.
81. Li,J.J., Jiang,C.R., Brown,J.B., Huang,H. and Bickel,P.J. (2011) Sparse linear modeling of next-generation mRNA sequencing (RNA-Seq) data for isoform discovery and abundance estimation. Proc. Natl Acad. Sci. USA, 108, 19867-19872.
82. Gong,T., Hartmann,N., Kohane,I.S., Brinkmann,V., Staedtler,F., Letzkus,M., Bongiovanni,S. and Szustakowski,J.D. (2011) Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samples. PLoS One, 6, e27156.
83. Repsilber,D., Kern,S., Telaar,A., Walzl,G., Black,G.F., Selbig,J., Parida,S.K., Kaufmann,S.H.E. and Jacobsen,M. (2010) Biomarker discovery in heterogeneous tissue samples-taking the in-silico deconfounding approach. BMC Bioinformatics, 11, 27.
84. Erkkilä ,T., Lehmusvaara,S., Ruusuvuori,P., Visakorpi,T., Shmulevich,I. and Lähdesmä ki,H. (2010) Probabilistic analysis of gene expression measurements from heterogeneous tissues. Bioinformatics, 26, 2571-2577.
85. Quon,G. and Morris,Q. (2009) ISOLATE: a computational strategy for identifying the primary origin of cancers using highthroughput sequencing. Bioinformatics, 25, 2882-2889.
86. Shen-Orr,S.S., Tibshirani,R., Khatri,P., Bodian,D.L., Staedtler,F., Perry,N.M., Hastie,T., Sarwal,M.M., Davis,M.M. and Butte,A.J. (2010) Cell type-specific gene expression differences in complex tissues. Nat. Methods, 7, 287-289.
87. Dunson,D.B. (2010) Nonparametric Bayes applications to biostatistics. In: Hjort,N.L., Holmes,C., Müller,P. and Walker,S.G. (eds), Bayesian Nonparametrics, Vol.28 Cambridge University Press, Cambridge, pp. 223-273.
88. Farris,J.S. (1966) Estimation of conservatism of characters by constancy within biological populations. Evolution, 20, 587-591.
89. Kluge,A.G. and Farris,J.S. (1969) Quantitative phyletics and the evolution of anurans. Syst. Biol., 18, 1-32.
90. Huelsenbeck,J.P., Ronquist,F., Nielsen,R. and Bollback,J.P. (2001) Bayesian inference of phylogeny and its impact on evolutionary biology. Science, 294, 2310-2314. (Pubitemid 33140548)
91. Doyon,J.P., Ranwez,V., Daubin,V. and Berry,V. (2011) Models, algorithms and programs for phylogeny reconciliation. Brief. Bioinform., 12, 392-400.
92. Chen,S.C. and Lindsay,B.G. (2006) Building mixture trees from binary sequence data. Biometrika, 93, 843-860. (Pubitemid 44973872)
93. Kannan,L. and Wheeler,W.C. (2012) Maximum Parsimony on Phylogenetic networks. Algorithms Mol. Biol., 7, 9.
94. von Heydebreck,A., Gunawan,B. and Fü zesi,L. (2004) Maximum likelihood estimation of oncogenetic tree models. Biostatistics, 5, 545-556. (Pubitemid 41180204)
95. Hjelm,M., Hö glund,M. and Lagergren,J. (2006) New probabilistic network models and algorithms for oncogenesis. J. Comput. Biol., 13, 853-865. (Pubitemid 43939097)
96. Radmacher,M.D., Simon,R., Desper,R., Taetle,R., Schä ffer,A.A. and Nelson,M.A. (2001) Graph models of oncogenesis with an application to melanoma. J. Theor. Biol., 212, 535-548. (Pubitemid 33015990)
97. Greenman,C.D., Pleasance,E.D., Newman,S., Yang,F., Fu,B., Nik-Zainal,S., Jones,D., Lau,K.W., Carter,N., Edwards,P.A. et al. (2012) Estimation of rearrangement phylogeny for cancer genomes. Genome Res., 22, 346-361.
98. Clement,M., Posada,D. and Crandall,K.A. (2000) TCS: a computer program to estimate gene genealogies. Mol. Ecol., 9, 1657-1659.
99. Chen,Z., Collins,A.M., Wang,Y. and Gaëta,B.A. (2010) Clustering-based identification of clonally-related immunoglobulin gene sequence sets. Immunome Res., 6(Suppl. 1), S4.
100. Desper,R., Jiang,F., Kallioniemi,O.P., Moch,H., Papadimitriou,C.H. and Schä ffer,A.A. (1999) Inferring tree models for oncogenesis from comparative genome hybridization data. J. Comput. Biol., 6, 37-51. (Pubitemid 29166360)
101. Desper,R., Jiang,F., Kallioniemi,O.P., Moch,H., Papadimitriou,C.H. and Schaffer,A.A. (2000) Distance-based reconstruction of tree models for oncogenesis. J. Comput. Biol., 7, 789-803.
102. Sprouffske,K., Pepper,J. and Maley,C.C. (2011) Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer. Prev. Res., 4, 1135-1144.
103. Tolliver,D., Tsourakakis,C., Subramanian,A., Shackney,S. and Schwartz,R. (2010) Robust unmixing of tumor states in array comparative genomic hybridization data. Bioinformatics, 26, i106-i114.
104. Schwartz,R. and Shackney,S.E. (2010) Applying unmixing to gene expression data for tumor phylogeny inference. BMC Bioinformatics, 11, 42.
105. Catanzaro,D., Ravi,R. and Schwartz,R. (2013) A mixed integer linear programming model to reconstruct phylogenies from single nucleotide polymorphism haplotypes under the maximum parsimony criterion Algorithms Mol. Biol., 8, 3.
106. Subramanian,A., Shackney,S. and Schwartz,R. (2012) Inference of tumor phylogenies from genomic assays on heterogeneous samples. J. Biomed. Biotechnol., 2012, 797812.
107. Parisi,F., Ariyan,S., Narayan,D., Bacchiocchi,A., Hoyt,K., Cheng,E., Xu,F., Li,P., Halaban,R. and Kluger,Y. (2011) Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies. BMC Genomics, 12, 230.
108. Yao,A. and Rubin,H. (1993) Automatic enumeration and characterization of heterogeneous clonal progression in cell transformation. Proc. Natl Acad. Sci. USA, 90, 10524-10528. (Pubitemid 23347074)
109. Malaise,E.P., Chavaudra,N. and Tubiana,M. (1973) The relationship between growth rate, labelling index and histological type of human solid tumours. Eur. J. Cancer., 9, 305-312.
110. Bozic,I., Antal,T., Ohtsuki,H., Carter,H., Kim,D., Chen,S., Karchin,R., Kinzler,K.W., Vogelstein,B. and Nowak,M.A. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA, 107, 18545-18550.
111. Kimmel,M. (2010) Evolution and cancer: a mathematical biology approach. Biol. Direct., 5, 29.
112. Moghaddasi,F.L., Bezak,E. and Marcu,L. (2012) In silico modelling of tumour margin diffusion and infiltration: review of current status. Comput. Math. Methods Med., 2012, 672895.
113. Mitelman,F., Johansson,B. and Mertens,F. (2012) Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. http://cgap.nci.nih.gov/ Chromosomes/Mitelman (10 July 2013, date last accessed).
114. Liu,M., Duke,J.L., Richter,D.J., Vinuesa,C.G., Goodnow,C.C., Kleinstein,S.H. and Schatz,D.G. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature, 451, 841-845. (Pubitemid 351253166)
115. Teng,G. and Papavasiliou,F.N. (2007) Immunoglobulin Somatic Hypermutation. Annu. Rev. Genet., 41, 107-120.
116. Anderson,S.M., Khalil,A., Uduman,M., Hershberg,U., Louzoun,Y., Haberman,A.M., Kleinstein,S.H. and Shlomchik,M.J. (2009) Taking advantage: high-affinity B cells in the germinal center have lower death rates, but similar rates of division, compared to low-affinity cells. J. Immunol., 183, 7314-7325.
117. Kleinstein,S.H. (2012) Computational laboratory for immunology & pathology. http://clip.med.yale.edu/trees/laser.html (10 July 2013, date last accessed).
118. Robinson,J., Malik,A., Parham,P., Bodmer,J.G. and Marsh,S.G.E. (2000) IMGT/HLA Database-a sequence database for the human major histocompatibility complex. Tissue Antigens, 55, 280-287. (Pubitemid 30150951)
119. Lefranc,M.P., Giudicelli,V., Kaas,Q., Duprat,E., Jabado-Michaloud,J., Scaviner,D., Ginestoux,C., Clément,O., Chaume,D. and Lefranc,G. (2005) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res., 33, D593-D597. (Pubitemid 40207943)
120. Parla,J.S., Iossifov,I., Grabill,I., Spector,M.S., Kramer,M. and McCombie,W.R. (2011) A comparative analysis of exome capture. Genome Biol., 12, R97.
121. Krauthammer,M., Kong,Y., Ha,B.H., Evans,P., Bacchiocchi,A., McCusker,J.P., Cheng,E., Davis,M.J., Goh,G., Choi,M. et al. (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet., 44, 1006-1014.
122. Langmead,B., Trapnell,C., Pop,M. and Salzberg,S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
123. Koboldt,D.C., Chen,K., Wylie,T., Larson,D.E., McLellan,M.D., Mardis,E.R., Weinstock,G.M., Wilson,R.K. and Ding,L. (2009) VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics, 25, 2283-2285.
124. Giardine,B., Riemer,C., Hardison,R.C., Burhans,R., Elnitski,L., Shah,P., Zhang,Y., Blankenberg,D., Albert,I., Taylor,J. et al. (2005) Galaxy: a platform for interactive large-scale genome analysis. Genome Res., 15, 1451-1455. (Pubitemid 41400913)
125. Borchardt,C.W. (1860) Über eine Interpolationsformel fü r eine Art Symmetrischer Functionen und ü ber Deren Anwendung. Math. Abh. der Akademie der Wissenschaften zu Berlin, 1-20.
126. Cayley,A. (1889) A theorem on trees. Q. J. Math, 23, 376-378.
127. Pfeifer,G.P., You,Y.H. and Besaratinia,A. (2005) Mutations induced by ultraviolet light. Mutat. Res., 571, 19-31. (Pubitemid 40313429)
128. Mardis,E.R., Ding,L., Dooling,D.J., Larson,D.E., McLellan,M.D., Chen,K., Koboldt,D.C., Fulton,R.S., Delehaunty,K.D., McGrath,S.D. et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med., 361, 1058-1066.
129. Fraley,C. and Raftery,A.E. (1999) MCLUST: Software for model-based cluster analysis. J. Classif., 16, 297-306.
130. Fraley,C. and Raftery,A.E. (1999) Enhanced model-based clustering, density estimation, and discriminant analysis software: MCLUST. J. Classif., 20, 263-286. (Pubitemid 38157158)
131. Hicklin,J., Moler,C., Webb,P., Boisvert,R., Miller,B., Pozo,R. and Remington,K. (2000) JAMA: A Java matrix package. http:// math.nist.gov/ javanumerics/jama/ (10 July 2013, date last accessed).
132. Fisher,D., O'Madadhain,J., Smyth,P., White,S. and Boey,Y.-B. (2005) Analysis and Visualization of Network Data using JUNG. J. Stat. Softw. http://www.ics.uci.edu/-smyth/kddpapers/ UCI-KD-D-JUNG-preprint.pdf (10 July 2013, date last accessed).
133. Thompson,F.H., Emerson,J., Olson,S., Weinstein,R., Leavitt,S.A., Leong,S.P., Emerson,S., Trent,J.M., Nelson,M.A., Salmon,S.E. et al. (1995) Cytogenetics of 158 patients with regional or disseminated melanoma Subset analysis of near-diploid and simple karyotypes. Cancer Genet. Cytogenet., 83, 93-104.
134. Junker,K., Schlichter,A., Junker,U., Knö fel,B., Kosmehl,H., Schubert,J. and Claussen,U. (1997) Cytogenetic, histopathologic, and immunologic studies of multifocal renal cell carcinoma. Cancer, 79, 975-981. (Pubitemid 27089881)
135. Huber,P.J. (1981) Robust Statistics. Wiley, New York, p.181
136. Bernet,A. and Fitamant,J. (2008) Netrin-1 and its receptors in tumour growth promotion. Expert. Opin. Ther. Targets, 12, 995-1007.